Hormonal Changes in Women Patients with Polycystic Ovary Syndrome (PCOS)

Nagham Hasan Ali


In Iraqi women theirs problem related to polycystic ovary syndrome, therefor the present study focus in these women patients and aimed to determine the hormonal changes in the class of these women the hormonal changes included  Follicle-stimulating hormone FSH, Luteinizing hormone LH, and Prolactin (PRL) and study the correlation between theme using statistical analysis, to achieve good results from current research 30 specimens of blood   were  collected  from 45  patients  with  PCOS  and  30  healthy  between  27  and 44  old  year's  consider- as  control  samples   attending  the  private  clinic  in  Baghdad governorate   from  the period  November  2015  to  June  2016.  All  samples were  inoculated  to  study  different  characteristics  of  hormones.  The   results  obtained  from  statistical  analysis  appeared  that  there's  significant difference  between  the  studied  hormones  P ≥ 0.05  also  there's  high significant  difference  in  the  titration  of  the  same  hormone  in the  patients  based  on  the  age of  women  patients' blood was hormonal assay results revealed a gradual decrease in serum FSH levels with a concomitant increase in Serum LH hormone level , when compared with control healthy also there's depression in Prolactin in thyroid  cancer  patients  Compared with  control healthy.



PCOS; hormonal changes; ELIsA.


Ehrmann DA: Polycystic ovary syndrome. N Engl J Med 2005, 352:1223–12236.

Norman RJ, Masters S, Hague W: Hyperinsulinemia is common in family members of women with polycystic ovary syndrome. Fertil Steril 1996, 66:942–947.

Simoni M, Tempfer CB, Destenaves B, Fauser BC: Functional genetic polymorphisms and female reproductive disorders: Part I: Polycystic ovary syndrome and ovarian response. Hum Reprod Update 2008, 14:459–484.

Gromoll J, Simoni M, Nordhoff V, Behre HM, De Geyter C, Nieschlag E: Functional and clinical consequences of mutations in the FSH receptor. Mol Cell Endocrinol 1996, 125:177–182.

Aittomaki K, Lucena JD, Pakarinen P, Sistonen P, Tapanainen J, Gromoll J, Kaskikari R, Sankila EM, Lehvaslaiho H, Engel AR, Nieschlag E, Huhtaniemi I, De la Chapelle A: Mutation in the follicle-stimulating hormone receptor gene causes hereditary hypergonadotropic ovarian failure. Cell 1995, 82:959–968.

Gromoll J, Simoni M: Genetic complexity of FSH receptor function. Trends Endocrinol Metab 2005, 16:368–373.

Conway GS, Conway E, Walker C, Hoppner W, Gromoll J, Simoni M: Mutation screening and isoform prevalence of the follicle stimulating hormone receptor gene in women with premature ovarian failure, resistant ovary syndrome and polycystic ovary syndrome. Clin Endocrinol (Oxf ) 1999, 51:97–99.

Tong Y, Liao WX, Roy AC, Ng SC: Absence of mutations in the coding regions of follicle-stimulating hormone receptor gene in Singapore Chinese women with premature ovarian failure and polycystic ovary syndrome. Horm Metab Res 2001, 33:221–226.

Sudo S, Kudo M, Wada S, Sato O, Hsueh AJ, Fujimoto S: Genetic and functional analyses of polymorphisms in the human FSH receptor gene. Mol Hum Reprod 2002, 8:893–899.

Katz P, Bellet N, less M.CEDIATM total an automated homogenous enzyme-immunoassay for serum total fsh,testosteron. Clin Chem.1991;37:9936.

Steel, RG. and Torries JH. (1980). Principal and Procedures of Statistics. Abiometrical approach 2nd Ed. McGraw - Hill Book Company. New York USA.

Overbeek A, Kuijper EA, Hendriks ML, Blankenstein MA, Ketel IJ, Twisk JW, Hompes PG, Homburg R, Lambalk CB: Clomiphene citrate resistance in relation to follicle-stimulating hormone receptor Ser680Ser-polymorphism in polycystic ovary syndrome. Hum Reprod 2009, 24:2007–2013.

Carmina E, Koyama T, Chang L, Stanczyk FZ, Lobo RA: Does ethnicity influence the prevalence of adrenal hyperandrogenism and insulin resistance in polycystic ovary syndrome? Am J Obstet Gynecol 1992, 167:1807–1812.

Saiki, R. 1989. Chapter 1. In PCR Technology: Principles and Applications for DNA Amplification, H. A. Erlich (Ed.). Stockton Press, New York

Knochenhauer ES, Key TJ, Kahsar-Miller M, Waggoner W, Boots LR, Azziz R: Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. J Clin Endocrinol Metab 1998, 83:3078–3082.

Diamanti-Kandarakis E, Kouli CR, Bergiele AT, Filandra FA, Tsianateli TC, Spina GG, Zapanti ED, Bartzis MI: A survey of the polycystic ovary syndrome inthe Greek island of Lesbos: hormonal and metabolic profile. J Clin Endocrinol Metab 1999, 84:4006–4011.

Wijeyaratne CN, Balen AH, Barth JH, Belchetz PE: Clinical manifestations and insulin resistance (IR) in polycystic ovary syndrome (PCOS) among South Asians and Caucasians: is there a difference? Clin Endocrinol (Oxf ) 2002, 57:343–345.

Vutyavanich T, Khaniyao V, Wongtra-Ngan S, Sreshthaputra O, Sreshthaputra R, Piromlertamorn W: Clinical, endocrine and ultrasonographic features of polycystic ovary syndrome in Thai women. J Obstet Gynaecol Res 2007, 33:677–680.

Lussiana C, Guani B, Mari C, Restagno G, Massobrio M, Revelli A: Mutations and polymorphisms of the FSH receptor (FSHR) gene: clinical implications in female fecundity and molecular biology of FSHR protein and gene. Obstet Gynecol Surv 2008, 63:785–789.

Full Text: PDF


  • There are currently no refbacks.

Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.



About IJSBAR | Privacy PolicyTerms & ConditionsContact UsDisclaimerFAQs

IJSBAR is published by (GSSRR).

 Plagiarism Policy